Literature DB >> 18323505

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Alida A Gouw1, Wiesje M van der Flier, Franz Fazekas, Elisabeth C W van Straaten, Leonardo Pantoni, Anna Poggesi, Domenico Inzitari, Timo Erkinjuntti, Lars O Wahlund, Gunhild Waldemar, Reinhold Schmidt, Philip Scheltens, Frederik Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: We studied the natural course of white matter hyperintensities (WMH) and lacunes, the main MRI representatives of small vessel disease, over time and evaluated possible predictors for their development.
METHODS: Baseline and repeat MRI (3-year follow-up) were collected within the multicenter, multinational Leukoaraiosis and Disability study (n=396). Baseline WMH were scored on MRI by the Fazekas scale and the Scheltens scale. WMH progression was assessed using the modified Rotterdam Progression scale (absence/presence of progression in 9 brain regions). Baseline and new lacunes were counted per region. WMH and lacunes at baseline and vascular risk factors were evaluated as predictors of WMH progression and new lacunes.
RESULTS: WMH progressed (mean+/-SD=1.9+/-1.8) mostly in the subcortical white matter, where WMH was also most prevalent at baseline. The majority of new lacunes, which were found in 19% of the subjects (maximum=9), also appeared in the subcortical white matter, mainly of the frontal lobes, whereas most baseline lacunes were located in the basal ganglia. Baseline WMH and lacunes predicted both WMH progression and new lacunes. Furthermore, previous stroke, diabetes, and blood glucose were risk factors for WMH progression. Male sex, hypertension, systolic blood pressure, previous stroke, body mass index, high-density lipoprotein, and triglyceride levels were risk factors for new lacunes.
CONCLUSIONS: WMH and lacunes progressed over time, predominantly in the subcortical white matter. Progression was observed especially in subjects with considerable WMH and lacunes at baseline. Moreover, the presence of vascular risk factors at baseline predicted WMH progression and new lacunes over a 3-year period.

Entities:  

Mesh:

Year:  2008        PMID: 18323505     DOI: 10.1161/STROKEAHA.107.498535

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  119 in total

Review 1.  The declining infrastructure of the aging brain.

Authors:  David H Salat
Journal:  Brain Connect       Date:  2011

2.  Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.

Authors:  Jose Gutierrez; Andrea Gil-Guevara; Srinath Ramaswamy; Janet DeRosa; Marco R Di Tullio; Ken Cheung; Tatjana Rundek; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  Stroke       Date:  2019-11-26       Impact factor: 7.914

3.  Leukoaraiosis severity and list-learning in dementia.

Authors:  Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon
Journal:  Clin Neuropsychol       Date:  2009-08       Impact factor: 3.535

Review 4.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

5.  Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants.

Authors:  Naftali Raz; Yiqin Yang; Cheryl L Dahle; Susan Land
Journal:  Biochim Biophys Acta       Date:  2011-08-25

6.  Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa
Journal:  Age (Dordr)       Date:  2016-09-23

7.  Association of white matter hyperintensities with low serum 25-hydroxyvitamin D levels.

Authors:  J M Prager; C Thomas; W J Ankenbrandt; J R Meyer; Y Gao; A Ragin; S Sidharthan; R Hutten; Y G Wu
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-16       Impact factor: 3.825

Review 8.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

9.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

10.  Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study.

Authors:  Jose Gutierrez; Mitchell S V Elkind; Ken Cheung; Tatjana Rundek; Ralph L Sacco; Clinton B Wright
Journal:  J Hypertens       Date:  2015-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.